• Explore /
  • Poster
  • / Drug-drug interactions (DDIs) in elderly patients with metastatic renal cell carcinoma (mRCC) treated with cabozantinib within the multicenter prospective trial ZEBRA/Meet-URO 9.

Drug-drug interactions (DDIs) in elderly patients with metastatic renal cell carcinoma (mRCC) treated with cabozantinib within the multicenter prospective trial ZEBRA/Meet-URO 9.

Abstract Poster

Authors

null

Alvise Mattana

Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy

Alvise Mattana , Marzia Del Re , Davide Bimbatti , Sebastiano Buti , Melanie Claps , Marilena Di Napoli , Lucia Fratino , Daniele Santini , Mariella Sorarù , Francesco Grillone , Giulia Mazzaschi , Marco Maruzzo , Francesco Pierantoni , Melissa Ballestrin , Chiara De Toni , Eleonora Lai , Michele Dionese , Vittorina Zagonel , Umberto Basso

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 648)

DOI

10.1200/JCO.2023.41.6_suppl.648

Abstract #

648

Poster Bd #

F18

Abstract Disclosures

Similar Posters

First Author: Annalisa Guida

First Author: Umberto Basso

First Author: Thomas Hilser

First Author: Viktor Grünwald